Connection

Silvio Danese to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications Silvio Danese has written about Injections, Subcutaneous.
Silvio Danese
Connection Strength
0.120
Injections, Subcutaneous
  1. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2019 09 26; 381(13):1201-1214.
    View in: PubMed
    Score: 0.042
  2. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. N Engl J Med. 2019 09 26; 381(13):1215-1226.
    View in: PubMed
    Score: 0.042
  3. Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2017 07 08; 390(10090):135-144.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.